Determination of the activated form of the progesterone receptor (PR) in endometrial cancer (EC).
Dinny Graham
Consultant or Advisory Role - Arno Therapeutics
Honoraria - Arno Therapeutics
Jacques Bosq
Consultant or Advisory Role - Invivis
Jean-Michel Caillaud
No relevant relationships to disclose
Matthew A. Powell
Consultant or Advisory Role - Arno Therapeutics; Eisai; Merck
Eric Leblanc
Consultant or Advisory Role - Arno Therapeutics
Honoraria - Arno Therapeutics
Keiichi Fujiwara
Consultant or Advisory Role - Arno Therapeutics
Thomas J. Herzog
Consultant or Advisory Role - Arno Therapeutics
Bradley J. Monk
Consultant or Advisory Role - Arno Therapeutics
Honoraria - Arno Therapeutics
Christine Clarke
No relevant relationships to disclose
Alexander A. Zukiwski
Employment or Leadership Position - Arno Therapeutics
Consultant or Advisory Role - Invivis (U)
Stock Ownership - Arno Therapeutics
Research Funding - Arno Therapeutics
Erard M. Gilles
Employment or Leadership Position - Invivis
Consultant or Advisory Role - Arno Therapeutics
Stock Ownership - Invivis
Robert L. Coleman
Consultant or Advisory Role - Arno Therapeutics; AstraZeneca; Esperance Pharmaceuticals; MedImmune; Merck; Novartis; Roche